Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial

This study will comply with the CONSORT guidelines. The projected s ample size requirement is 36 participants in a crossover trial giving a power of 80 % and a type-1 error rate of 0.05.DiscussionMIDAS seeks to enhance the quality of life in stroke survivors by assisting or resolving stroke-associated fatigue.Trial registrationACTRN12615000350527, registered on the 17 April 2015.Protocol version 3, approved 16 June 2015.

http://link.springer.com/10.1186/s13063-016-1537-4

Source: Trials - August 16, 2016 Category: Research Source Type: clinical trials